Concepedia

Meghan M. Bell

MM

6

Publications

230

Citations

6

H-Index

2018

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

National Institutes of Health

National Cancer Institute

Meghan M. Bell is an author at Memorial Sloan Kettering Cancer Center specializing in tumor immunity, medicine, and t cell immunity.

ORCID

Top concepts

Publications per year

2018–2022

6

Publications

6

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma

Meghan M. Bell, Nicholas T. Gutsche, Anna King et al. · Molecules · 2020 · 50 citations · Full text

Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes

Simone Krebs, Afruja Ahad, Lukas M. Carter et al. · Journal of Nuclear Medicine · 2018 · 48 citations · Full text

, , +22

Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative doses

Sarah M. Cheal, Michael R. McDevitt, Brian H. Santich et al. · Theranostics · 2020 · 43 citations · Full text

Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma

Sarah M. Cheal, Hong Xu, Hong-Fen Guo et al. · Theranostics · 2018 · 38 citations · Full text

<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

Anna King, Nicholas T. Gutsche, Natarajan Raju et al. · Journal of Nuclear Medicine · 2022 · 35 citations · Full text

Rows per page

1–5 of 6